Faqs on Valdecoxib

These are some Faqs on Valdecoxib:

The chemical name for Bextra® is Valdecoxib and it is a non-steroidal anti-inflammatory drug (NSAIDs), known as a COX-2 selective agent. It is prescribed for inflammation and pain from arthritis or menstrual cramping. Other drugs in this class include Celebrex® and Vioxx®.

On April 7, 2005 the FDA announced that it has asked Pfizer, Inc. to withdraw Bextra® or Valdecoxib from the market "because the overall risk versus benefit profile for the drug is unfavorable."

Side Effects for Valdecoxib tablets include the following:

Potential for increased risk of cardiovascular events
Gastrointestinal bleeding
Serious skin reactions, some resulting in death.

FDA INFORMATION

To read the FDA's announcement withdrawing Bextra.

Click here to read the FDA questions and answers about strengthened warnings on Bextra® boxes.

To report any unexpected adverse or serious events associated with the use of Bextra® contact the FDA MedWatch program on the internet or at 1-800-FDA-1088

bextra site map

Autism Education Materials!